GB Patent

GB201713784D0 — Modulators of hedgehog (Hh) Signalling pathway

Assigned to E Therapeutics PLC · Expires 2017-10-11 · 9y expired

What this patent protects

Patent listed against Erivedge.

Drugs covered by this patent

Patent Metadata

Patent number
GB201713784D0
Jurisdiction
GB
Classification
—
Expires
2017-10-11
Drug substance claim
No
Drug product claim
No
Assignee
E Therapeutics PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.